Table 6 Summary of AAN evidence-based guidelines level A or B recommendation for use

DrugNewly diagnosed monotherapy partial/mixedNewly diagnosed absence
* Not Food and Drug Administration-approved for this indication.
GabapentinYes*No
LamotrigineYes*Yes*
TopiramateYes*No
TiagabineNoNo
OxcarbazepineYesNo
LevetiracetamNoNo
ZonisamideNoNo